These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

724 related items for PubMed ID: 18070184

  • 21. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer.
    Perez RO, São Julião GP, Habr-Gama A, Kiss D, Proscurshim I, Campos FG, Gama-Rodrigues JJ, Cecconello I.
    Dis Colon Rectum; 2009 Jun; 52(6):1137-43. PubMed ID: 19581858
    [Abstract] [Full Text] [Related]

  • 22. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Bertolini F, Bengala C, Losi L, Pagano M, Iachetta F, Dealis C, Jovic G, Depenni R, Zironi S, Falchi AM, Luppi G, Conte PF.
    Int J Radiat Oncol Biol Phys; 2007 Aug 01; 68(5):1455-61. PubMed ID: 17445998
    [Abstract] [Full Text] [Related]

  • 23. [T4 rectal carcinoma. Surgical and multimodal therapy].
    Rau B, Hohenberger P, Gellermann J, Hünerbein M, Hildebrandt B, Schneider U, Riess H, Wust P, Schlag PM.
    Chirurg; 2002 Feb 01; 73(2):147-53. PubMed ID: 11974478
    [Abstract] [Full Text] [Related]

  • 24. Combined-modality therapy with sphincter-preserving total mesorectal excision for locally advanced rectal cancer: patient's age and long-term outcome.
    Szynglarewicz B, Matkowski R, Maciejczyk A, Kasprzak P, Forgacz J, Pudelko M.
    J Gastrointestin Liver Dis; 2008 Mar 01; 17(1):49-52. PubMed ID: 18392244
    [Abstract] [Full Text] [Related]

  • 25. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M, Chu Q, Burton G, Ampil F, Mizell J, Li BD.
    Am Surg; 2005 Jun 01; 71(6):487-92. PubMed ID: 16044927
    [Abstract] [Full Text] [Related]

  • 26. Predictors of disease-free survival in rectal cancer patients undergoing curative proctectomy.
    Stewart D, Yan Y, Mutch M, Kodner I, Hunt S, Lowney J, Birnbaum E, Read T, Fleshman J, Dietz D.
    Colorectal Dis; 2008 Nov 01; 10(9):879-86. PubMed ID: 19037929
    [Abstract] [Full Text] [Related]

  • 27. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
    Ceelen W, Boterberg T, Pattyn P, van Eijkeren M, Gillardin JM, Demetter P, Smeets P, Van Damme N, Monsaert E, Peeters M.
    Ann Surg Oncol; 2007 Feb 01; 14(2):424-31. PubMed ID: 17096057
    [Abstract] [Full Text] [Related]

  • 28. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB, Choi HS, Jeong SY, Kim DY, Jung KH, Hong YS, Chang HJ, Park JG.
    Ann Surg; 2008 Aug 01; 248(2):243-51. PubMed ID: 18650634
    [Abstract] [Full Text] [Related]

  • 29. The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer.
    Berho M, Oviedo M, Stone E, Chen C, Nogueras J, Weiss E, Sands D, Wexner S.
    Colorectal Dis; 2009 Mar 01; 11(3):254-8. PubMed ID: 18513188
    [Abstract] [Full Text] [Related]

  • 30. Short versus conventional preoperative radiotherapy of rectal cancer: indications.
    Klenova A, Georgiev R, Kurtev P, Kurteva G.
    J BUON; 2007 Mar 01; 12(2):227-32. PubMed ID: 17600877
    [Abstract] [Full Text] [Related]

  • 31. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?
    Mawdsley S, Glynne-Jones R, Grainger J, Richman P, Makris A, Harrison M, Ashford R, Harrison RA, Osborne M, Livingstone JI, MacDonald P, Mitchell IC, Meyrick-Thomas J, Northover JM, Windsor A, Novell R, Wallace M.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):745-52. PubMed ID: 16199310
    [Abstract] [Full Text] [Related]

  • 32. Rectal cancer surgery in the elderly: a multivariate analysis of outcome risk factors.
    Bufalari A, Giustozzi G, Burattini MF, Servili S, Bussotti C, Lucaroni E, Ricci E, Sciannameo F.
    J Surg Oncol; 2006 Mar 01; 93(3):173-80. PubMed ID: 16482596
    [Abstract] [Full Text] [Related]

  • 33. Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma.
    Gosens MJ, Klaassen RA, Tan-Go I, Rutten HJ, Martijn H, van den Brule AJ, Nieuwenhuijzen GA, van Krieken JH, Nagtegaal ID.
    Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6617-23. PubMed ID: 18006762
    [Abstract] [Full Text] [Related]

  • 34. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C, Nobili S, Rullier A, Vendrely V, Saric J, Rullier E.
    J Am Coll Surg; 2006 Nov 15; 203(5):684-91. PubMed ID: 17084330
    [Abstract] [Full Text] [Related]

  • 35. Preoperative radiochemotherapy and radical resection for stages II to IV oral and oropharyngeal cancer: grade of regression as crucial prognostic factor.
    Klug C, Wutzl A, Kermer C, Ploder O, Sulzbacher I, Selzer E, Voracek M, Oeckher M, Ewers R, Millesi W.
    Int J Oral Maxillofac Surg; 2005 May 15; 34(3):262-7. PubMed ID: 15741034
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
    Jeyarajah S, Sutton CD, Miller AS, Hemingway D, Leicester Colorectal Specialist Group.
    Colorectal Dis; 2007 Nov 15; 9(9):808-15. PubMed ID: 17441969
    [Abstract] [Full Text] [Related]

  • 38. Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low anterior resection.
    Luna-Pérez P, Bustos-Cholico E, Alvarado I, Maffuz A, Rodríguez-Ramírez S, Gutiérrez de la Barrera M, Labastida S.
    J Surg Oncol; 2005 Apr 01; 90(1):20-5. PubMed ID: 15786412
    [Abstract] [Full Text] [Related]

  • 39. Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer.
    Supiot S, Bennouna J, Rio E, Meurette G, Bardet E, Buecher B, Dravet F, Le Neel JC, Douillard JY, Mahé MA, Lehur PA.
    Colorectal Dis; 2006 Jun 01; 8(5):430-5. PubMed ID: 16684088
    [Abstract] [Full Text] [Related]

  • 40. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
    Lombardi R, Cuicchi D, Pinto C, Di Fabio F, Iacopino B, Neri S, Tardio ML, Ceccarelli C, Lecce F, Ugolini G, Pini S, Di Tullio P, Taffurelli M, Minni F, Martoni A, Cola B.
    Ann Surg Oncol; 2010 Mar 01; 17(3):838-45. PubMed ID: 20012700
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.